AtriCure, Inc. (ATRC) analyst actions
Rating and price-target actions on ATRC in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ATRC overview →
No ATRC analyst action events in the measured window.
Nothing matched in the current window — the ATRC overview has every event we measure for this name.
Get an email when ATRC moves on news →Keep exploring
More ATRC: earnings → · SEC filings → · ATRC overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CORREVIO PHARMA CORP ORDINARY SHARES (CORV) | 279 | 0.00% | 44% |
| Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares (CANF) | 278 | -0.48% | 36% |
| Coherus Oncology, Inc. (CHRS) | 276 | +0.21% | 51% |
| Xenon Pharmaceuticals Inc. - Common Shares (XENE) | 276 | +0.03% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.